Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 50022510
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of p110 alpha (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of p110 delta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of p110 beta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of p110 gamma (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of p110 delta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of p110 alpha (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of p110 delta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of p110 alpha (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of p110 delta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of p110 alpha (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of human recombinant PI3K delta using ethylenediaminetetraacetic and PIP2 as a substrate incubated for 20 mins in presence of ATP by HTRF ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of p110 delta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of p110 alpha (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of p110 delta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of p110 gamma (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of p110 gamma (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of p110 gamma (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of p110 gamma (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibition of p110 alpha (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibition of human recombinant PI3K alpha using ethylenediaminetetraacetic and PIP2 as a substrate incubated for 20 mins in presence of ATP by HTRF ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Inhibition of p110 gamma (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Inhibition of p110 beta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibition of p110 beta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:Inhibition of p110 delta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Inhibition of p110 alpha (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Inhibition of p110 alpha (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 43nMAssay Description:Inhibition of p110 delta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 44nMAssay Description:Inhibition of p110 beta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 44nMAssay Description:Inhibition of human recombinant PI3K beta using ethylenediaminetetraacetic and PIP2 as a substrate incubated for 20 mins in presence of ATP by HTRF a...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 49nMAssay Description:Inhibition of p110 gamma (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 49nMAssay Description:Inhibition of human recombinant PI3K gamma using ethylenediaminetetraacetic and PIP2 as a substrate incubated for 20 mins in presence of ATP by HTRF ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 52nMAssay Description:Inhibition of p110 alpha (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 75nMAssay Description:Inhibition of p110 gamma (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 76nMAssay Description:Inhibition of p110 beta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 113nMAssay Description:Inhibition of p110 beta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 116nMAssay Description:Inhibition of p110 delta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 166nMAssay Description:Inhibition of p110 beta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 262nMAssay Description:Inhibition of p110 gamma (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Inhibition of p110 beta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 383nMAssay Description:Inhibition of p110 beta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of p110 delta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 2.90E+4nMAssay Description:Inhibition of p110 gamma (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 7.50E+4nMAssay Description:Inhibition of p110 beta (unknown origin)More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cancer Chemotherapy Center
Curated by ChEMBL
Cancer Chemotherapy Center
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of p110 alpha (unknown origin)More data for this Ligand-Target Pair







3D Structure (crystal)

